- Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy.
- van Winden LJ, Vermeulen RFM, van den Noort V, Gaarenstroom KN, Kenter GG, Brood-van Zanten MMA, Korse CM, van Beurden M, van Rossum HH.
- J Endocr Soc. 2022 Apr 25 [eCollection 2022 Jun];6(6):bvac069. doi: 10.1210/jendso/bvac069.
- PMID: 35592509
- PubMed abstract
- Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility.
- Koivuluoma S, Vorimo S, Mattila TM, Tervasmäki A, Kumpula T, Kuismin O, Winqvist R, Moilanen J, Mantere T, Pylkäs K.
- Fam Cancer. 2022 May 20. doi: 10.1007/s10689-022-00295-z. Epub ahead of print.
- PMID: 35590014
- PubMed abstract
- Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
- Yap TA, Ashok A, Stoll J, Mauer E, Nepomuceno VM, Blackwell KL, Garber JE, Meric-Bernstam F.
- JAMA Netw Open. [2022 May 20];5(5):e2213070. doi: 10.1001/jamanetworkopen.2022.13070.
- PMID: 35594047
- PubMed abstract
Ccommentary:
Paired Tumor-Germline Testing as a Driver in Better Cancer Care.
- PMID: 35594050
- PubMed abstract
- Free Full Text
- Breast cancer risk for transgender men with inherited mutations.
- [No author given]
- FORCE. XRAY. 2022 May 19.
- Research news
- Free Full Text
Commentary:
BRCA Mutations and the Implications in Transgender Individuals Undergoing Top Surgery: An Operative Dilemma.
- PMID: 35028250
- PubMed abstract
- Free Full Text
- Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors.
- Huszno J, Kolosza Z, Mrochem-Kwarciak J, Grzybowska E.
- Arch Med Sci. 2022 Apr 14;18(3):800-804. doi: 10.5114/aoms/147736.
- PMID: 35591831
- PubMed abstract